» Articles » PMID: 38921737

Characterization of CRISPR-Cas Systems in and : Insights into the Adaptation and Survival of Marine Pathogens

Overview
Journal Pathogens
Date 2024 Jun 26
PMID 38921737
Authors
Affiliations
Soon will be listed here.
Abstract

CRISPR-Cas systems are adaptive immune mechanisms present in most prokaryotes that play an important role in the adaptation of bacteria and archaea to new environments. is a marine zoonotic pathogen with worldwide distribution, which accounts for the majority of clinical cases of infections. However, the characterization of CRISPR-Cas systems has not been well investigated yet. Through whole genome sequence analysis, we characterized the CRISPR-Cas systems in . Our results indicate that CRISPR-Cas systems are prevalent in , with the majority of strains containing the Type I-F system. This study provides new insights into the diversity and function of CRISPR-Cas systems in and highlights their potential role in the adaptation and survival of these marine pathogens.

References
1.
Chia-Wei L, Cheng J, Tung K, Hong Y, Lin J, Lin Y . Evolution of trimethoprim/sulfamethoxazole resistance in Shewanella algae from the perspective of comparative genomics and global phylogenic analysis. J Microbiol Immunol Infect. 2021; 55(6 Pt 2):1195-1202. DOI: 10.1016/j.jmii.2021.09.014. View

2.
Tyson G, Banfield J . Rapidly evolving CRISPRs implicated in acquired resistance of microorganisms to viruses. Environ Microbiol. 2007; 10(1):200-7. DOI: 10.1111/j.1462-2920.2007.01444.x. View

3.
Corts A, Thomason L, Gill R, Gralnick J . Efficient and Precise Genome Editing in with Recombineering and CRISPR/Cas9-Mediated Counter-Selection. ACS Synth Biol. 2019; 8(8):1877-1889. DOI: 10.1021/acssynbio.9b00188. View

4.
Zerbino D, Birney E . Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008; 18(5):821-9. PMC: 2336801. DOI: 10.1101/gr.074492.107. View

5.
Liu P, Lin C, Tung K, Shyu C, Wu M, Liu J . Clinical and microbiological features of shewanella bacteremia in patients with hepatobiliary disease. Intern Med. 2013; 52(4):431-8. DOI: 10.2169/internalmedicine.52.8152. View